ICMR has licensed the anti-HPV candidate SHetA2 to Emcure Pharmaceuticals for further development. The move could open a ...

SHetA2 targets HPV-infected cells while largely sparing healthy tissue. If successful, it could offer a less invasive treatment for cervical precancer.

Cryotherapy for cervical cancer is a medical procedure that involves using freezing gas to kill precancerous cells in the cervix. The body can then regenerate healthy cells. Cryotherapy, also known as ...

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...